Eupraxia Pharmaceuticals (TSE:EPRX)
TSX:EPRX
Holding TSE:EPRX?
Track your performance easily

Eupraxia Pharmaceuticals (EPRX) Income Statement

19 Followers

Eupraxia Pharmaceuticals Income Statement

Last quarter (Q2 2024), Eupraxia Pharmaceuticals's total revenue was C$―, a decrease of ― from the same quarter last year. In Q2, Eupraxia Pharmaceuticals's net income was C$-6.01M. See Eupraxia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-----C$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 28.64MC$ 27.95MC$ 23.62MC$ 18.68MC$ 2.25MC$ 6.16M
Operating Income
C$ -28.64MC$ -27.95MC$ -23.62MC$ -18.68MC$ -2.25MC$ -6.16M
Net Non Operating Interest Income Expense
C$ 372.22KC$ -307.20KC$ -1.02MC$ 1.23MC$ 1.88MC$ -1.45M
Other Income Expense
C$ -352.48KC$ 738.58KC$ -412.44KC$ -3.46MC$ 116.76KC$ 369.70K
Pretax Income
C$ -28.11MC$ -28.93MC$ -23.92MC$ -23.37MC$ -4.01MC$ -7.24M
Tax Provision
C$ 36.42KC$ 36.42K----
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -27.48MC$ -28.22MC$ -23.26MC$ -22.99MC$ -4.00MC$ -7.18M
Basic EPS
C$ -0.90C$ -1.17C$ -1.24C$ -1.88C$ -0.31C$ -0.56
Diluted EPS
C$ -0.90C$ -1.17C$ -1.24C$ -1.88C$ -0.31C$ -0.56
Basic Average Shares
C$ 117.31MC$ 24.15MC$ 19.29MC$ 12.41MC$ 12.87MC$ 12.87M
Diluted Average Shares
C$ 117.31MC$ 24.15MC$ 19.29MC$ 12.41MC$ 12.87MC$ 12.87M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-----C$ 133.50K
Total Expenses
C$ 28.64MC$ 27.95MC$ 23.62MC$ -18.68MC$ -2.25MC$ 6.16M
Net Income From Continuing And Discontinued Operation
C$ -27.48MC$ -28.22MC$ -23.26MC$ -22.99MC$ -4.00MC$ -7.18M
Normalized Income
C$ -23.85MC$ -21.26MC$ -17.57MC$ -17.18MC$ -2.82MC$ -7.55M
Interest Expense
-----C$ 1.46M
EBIT
C$ -27.40MC$ -27.76MC$ -22.33MC$ -22.07MC$ -2.13MC$ -5.78M
EBITDA
C$ -27.27MC$ -27.60MC$ -22.14MC$ -21.96MC$ -2.01MC$ -5.57M
Currency in CAD

Eupraxia Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis